Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Blood (2018) 132 (Supplement 1): 1966.

https://doi.org/10.1182/blood-2018-99-112851

Published: 2018

Journal Articles

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Meletios A. Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Erasmia Psimenou, Dimitrios Ziogas, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Panagiotidis, Argyrios Ntalianis, Evangelos Repasos, Elektra Papadopoulou, Kimon Stamatelopoulos, Efstathios Manios, Constantinos Pamboukas, Sofoklis Kontogiannis, Evangelos Terpos, Efstathios Kastritis, MD

Blood (2016) 128 (22): 4491.

https://doi.org/10.1182/blood.V128.22.4491.4491

Published: 2016

Journal Articles

Bortezomib-Based Triplets Are Associated with a High Probability of Dialysis Independence and Rapid Renal Recovery in Newly Diagnosed Myeloma Patients with Severe Renal Failure or Those Requiring Dialysis

Meletios A. Dimopoulos, Efstathios Kastritis, MD, Maria Roussou, Erasmia Psimenou, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios Ziogas, Ioannis Panagiotidis, Despoina Fotiou, Eftychia Kafantari, Stavroula Giannouli, Sofoklis Kontogiannis, Evangelos Terpos

Blood (2015) 126 (23): 1832.

https://doi.org/10.1182/blood.V126.23.1832.1832

Published: 2015

Journal Articles

Renal Outcomes in Patients with AL Amyloidosis: Evaluation of Prognostic Factors and Impact of Therapy with Novel Agents

Efstathios Kastritis, MD, Maria Roussou, Evangelos Terpos, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Despoina Kalapanida, Sofoklis Kontogiannis, Theofanis Apostolou, Ioannis Boletis, Constantinos Pamboukas, Savvas Th. Toumanidis, Elektra Papadopoulou, Erasmia Psimenou, Meletios A. Dimopoulos, MD

Blood (2014) 124 (21): 2130.

https://doi.org/10.1182/blood.V124.21.2130.2130

Published: 2014

Journal Articles

Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy

Meletios A. Dimopoulos, Evangelos Terpos, Maria Gavriatopoulou, Despoina Kalapanida, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Despoina Mparmparoussi, Athanasios Zomas, Dimitra Gika, Zafiris Kartasis, Charis Matsouka, Evangelos Kostis, Sofoklis Kontogiannis, Kostas Konstantopoulos, Efstathios Kastritis, MD

Blood (2014) 124 (21): 4738.

https://doi.org/10.1182/blood.V124.21.4738.4738

Published: 2014

Journal Articles

Growth Differentiation Factor-15 in Patients with Light Chain (AL) Amyloidosis Has Independent Prognostic Significance and Adds Prognostic Information Related to Risk of Early Death and Renal Outcomes

Efstathios Kastritis, MD, Ioannis Papassotiriou, PhD, Evangelos Terpos, Athanassios Akalestos, Erasmia Psimenou, Filia Apostolakou, Maria Roussou, Maria Gavriatopoulou, Elisavet Kaldara, Evangelos Eleutherakis-Papaiakovou, Despoina Kalapanida, Constantinos Pamboucas, Evangelos Kostis, Sofoklis Kontogiannis, Savvas Th. Toumanidis, Ioannis Boletis, Meletios A. Dimopoulos

Blood (2014) 124 (21): 306.

https://doi.org/10.1182/blood.V124.21.306.306

Published: 2014

Journal Articles

Validation Of Criteria For Renal Response In Patients With Multiple Myeloma (MM) Who Present With Severe Renal Dysfunction

Meletios A. Dimopoulos, MD, Evangelos Terpos, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Nikolaos Kanellias, Dimitrios Christoulas, Despoina Kalapanida, Despoina Mparmparoussi, Charis Matsouka, Sofoklis Kontogiannis, Evangelos Kostis, Erasmia Psimenou, Efstathios Kastritis

Blood (2013) 122 (21): 3176.

https://doi.org/10.1182/blood.V122.21.3176.3176

Published: 2013

NARROW

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Bortezomib-Based Triplets Are Associated with a High Probability of Dialysis Independence and Rapid Renal Recovery in Newly Diagnosed Myeloma Patients with Severe Renal Failure or Those Requiring Dialysis

Renal Outcomes in Patients with AL Amyloidosis: Evaluation of Prognostic Factors and Impact of Therapy with Novel Agents

Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy

Growth Differentiation Factor-15 in Patients with Light Chain (AL) Amyloidosis Has Independent Prognostic Significance and Adds Prognostic Information Related to Risk of Early Death and Renal Outcomes

Validation Of Criteria For Renal Response In Patients With Multiple Myeloma (MM) Who Present With Severe Renal Dysfunction

Email alerts

ASH Publications

American Society of Hematology

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Bortezomib-Based Triplets Are Associated with a High Probability of Dialysis Independence and Rapid Renal Recovery in Newly Diagnosed Myeloma Patients with Severe Renal Failure or Those Requiring Dialysis

Renal Outcomes in Patients with AL Amyloidosis: Evaluation of Prognostic Factors and Impact of Therapy with Novel Agents

Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy

Growth Differentiation Factor-15 in Patients with Light Chain (AL) Amyloidosis Has Independent Prognostic Significance and Adds Prognostic Information Related to Risk of Early Death and Renal Outcomes

Validation Of Criteria For Renal Response In Patients With Multiple Myeloma (MM) Who Present With Severe Renal Dysfunction

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only